The Application of Nitric Oxide for Ocular Hypertension Treatment
Despite of various therapeutic methods for treating ocular hypertension and glaucoma, it still remains the leading cause of irreversible blindness. Intraocular pressure (IOP) lowering is the most effective way to slow disease progression and prevent blindness. Among the ocular hypotensive drugs curr...
Main Authors: | Binze Han, Maomao Song, Liping Li, Xinghuai Sun, Yuan Lei |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/23/7306 |
Similar Items
-
Minimally Invasive Glaucoma Surgery: A Review of the Literature
by: Michael Balas, et al.
Published: (2023-08-01) -
Effect of topical nitric oxide donors 0.03% nitroglycerin and 0.1% hydralazine on intraocular pressure in healthy canine eyes
by: Parker A. Wilcox, et al.
Published: (2022-11-01) -
Glucocorticoid-Induced Ocular Hypertension and Glaucoma
by: Harvey DH, et al.
Published: (2024-02-01) -
Efficacy and safety of various brimonidine formulations in the treatment of glaucoma and ocular hypertension
by: A. V. Sidorova, et al.
Published: (2021-07-01) -
The Dual Effect of Rho-Kinase Inhibition on Trabecular Meshwork Cells Cytoskeleton and Extracellular Matrix in an In Vitro Model of Glaucoma
by: Juliette Buffault, et al.
Published: (2022-02-01)